Dong Song Wei

Corporate Secretary en SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. .

Fortuna: 24 739 $ al 31/03/2024

51 años

Health Technology

Perfil

Dong Song Wei currently works at Sinopharm YiXin Pharmaceutical Co., Ltd., as Director and Shanghai Shyndec Pharmaceutical Co., Ltd., as Board Secretary & Vice President from 2012.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. CLASS A 0.00%	14/04/2023	20 000 ( 0.00% )	24 739 $	31/03/2024

Cargos activos de Dong Song Wei

Empresas	Cargo	Inicio
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Corporate Secretary	09/01/2012
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Director/Board Member	-

Todos los cargos activos de Dong Song Wei

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Dong Song Wei.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
Sinopharm YiXin Pharmaceutical Co., Ltd. Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China.	Health Technology